plumbagin has been researched along with Acute Promyelocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, DP; Xu, KH | 1 |
| Lu, DP; Zhao, YL | 1 |
2 other study(ies) available for plumbagin and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Enzyme Activation; Humans; In Situ Nick-End Labeling; Leukemia, Promyelocytic, Acute; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred NOD; Mice, SCID; Naphthoquinones; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2010 |
[Effects of plumbagin on the human acute promyelocytic leukemia cells in vitro].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Leukemia, Promyelocytic, Acute; Naphthoquinones | 2006 |